Search Results 51-60 of 28135 for B cell lymphomas
In MZL, changes happen that turn the B lymphocytes into cancer cells. The cancer cells can grow in the lymph nodes, bone marrow, stomach, spleen and other parts ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
These conditions include such cancers as multiple myeloma, Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), and such precursor conditions as monoclonal ...
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin. ... B-cell lymphomas. Blood Cancer J. 2024 Oct ...
For stage 4 diffuse large B-cell lymphoma, the chance of surviving at least five years is about 55%. Follicular lymphoma is another common type of non-Hodgkin ...
Mayo Clinic doctors and researchers are studying B-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
Lymphoma cells collected from an endoscopy, lymph node biopsy, or bone ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...
Patients with large B-cell lymphoma who do not respond to an anthracycline-based front-line chemoimmunotherapy or who show evidence of relapse within 12 months ...
... lymphoma, Cutaneous t-cell lymphoma, Sezary s...yndrome, B-cell lymphoma, Burkitt lymphoma, Follicular lymphoma, T-cell lymphoma. Show more areas of focus ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.